Abstract

Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease

Dig Dis Sci. 2022 Jun;67(6):2462-2470. doi: 10.1007/s10620-021-07016-z. Epub 2021 Jun 22.

 

Aurélie Grandmougin # 1Ferdinando D'Amico # 2 3Thomas Remen 4Silvio Danese 2 5Marjorie Bonneton 6Marie Agnes Galloy 7Laurent Peyrin-Biroulet 3Valérie Laurent 8

 
     

Author information

1Department of Radiology, Nancy University Hospital, Lorraine University, 1 Allée du Morvan, 54511, Vandoeuvre-lès-Nancy, France.

2Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

3Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

4Methodology, Data Management and Statistic Unit, MPI Department, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.

5IBD Center, Humanitas Research Hospital-IRCCS, Rozzano, Milan, Italy.

6Department of Pediatric Gastroenterology, Hepatology and Nutrition, Childrens Hospital of Nancy, Vandoeuvre-le`s-Nancy, France.

7Department of Pediatric Radiology, Childrens University Hospital, Nancy, France.

8Department of Radiology, Nancy University Hospital, Lorraine University, 1 Allée du Morvan, 54511, Vandoeuvre-lès-Nancy, France. v_croiselaurent@yahoo.fr.

#Contributed equally.

Abstract

Background: The association between radiological remission and natural history of disease in children with inflammatory bowel diseases (IBD) is poorly known.

Aims: (i) To assess the correlation between cross-sectional imaging (CSI) (ultrasound and magnetic resonance imaging) and clinical, biomarker and endoscopic disease activity; (ii) to evaluate the impact of radiological activity on the occurrence of complications in pediatric patients with IBD.

Methods: A retrospective study including pediatric patients with IBD and radiological follow-up of at least one year was conducted between 2003 and 2019 at the Nancy University Hospital.

Results: In total, 118 patients (66 Crohn's disease (CD) and 52 ulcerative colitis (UC)) were included. Median follow-up duration was 5.2 years (range: 1.1-15.4). Seventeen (25.8%) patients with CD and 7 (13.5%) patients with UC achieved and maintained radiological remission until last follow-up. No IBD patient achieving radiological remission experienced complications or relapse. In patients not achieving radiologic remission, complications and surgery occurred in 13/49 (26.5%) and 8/49 (16.3%) patients with CD and in 5/45 (11.1%) and 5 (11.1%) subjects with UC. Among patients with CD, the association for remission status between radiological and endoscopic assessment was excellent (Cramer's V test (V) = 0.50), and moderate between radiological and either clinical (V = 0.30) or biochemical (V = 0.33) assessments. In UC, the association for remission status between radiological and either endoscopic or clinical assessments were weak (V = 0.19 and V = 0.20 respectively), and moderate (V = 0.23) between radiological and biochemical assessments.

Conclusion: CSI may replace endoscopic monitoring in pediatric CD. Radiological remission status predicts long-term disease outcomes.

 

© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.